Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franklin R Schneier

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Expert Opinion on Pharmacotherapy|January 19, 2011
Pharmacotherapy of social anxiety disorderFranklin R Schneier
The New England Journal of Medicine|September 8, 2006
Clinical practice. Social anxiety disorderFranklin R Schneier
BMJ (Clinical Research Ed.)|September 6, 2003
Social anxiety disorderFranklin R Schneier
Expert Review of Neurotherapeutics|September 10, 2024
When is pharmacological intervention recommended for adults with social anxiety disorder?Franklin R Schneier
Journal of Psychiatric Practice|September 14, 2004
Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatmentKenneth Belzer, Franklin R Schneier
Psychiatry Research|November 4, 2011
Neural response to eye contact and paroxetine treatment in generalized social anxiety disorderFranklin R Schneier, Marc Pomplun, Melissa Sy, et al.
Journal of Anxiety Disorders|June 11, 2022
Development and initial validation of the Visual Social Anxiety Scale (VSAS): Could a picture be worth a thousand words?Raz Massad, Nimrod Hertz-Palmor, Franklin R Schneier, et al.
Psychiatry Research|July 25, 2009
Neural circuitry of submissive behavior in social anxiety disorder: A preliminary study of response to direct eye gazeFranklin R Schneier, Justine M Kent, Ava Star, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2013
Reduced anterior temporal and hippocampal functional connectivity during face processing discriminates individuals with social anxiety disorder from healthy controls and panic disorder, and increases following treatmentSpiro P Pantazatos, Ardesheer Talati, Franklin R Schneier, et al.
The International Journal of Neuropsychopharmacology|November 12, 2003
The evidence-based pharmacological treatment of social anxiety disorderCarlos Blanco, Muhammad S Raza, Franklin R Schneier, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|January 19, 2011
Pharmacotherapy of social anxiety disorderFranklin R Schneier
The New England Journal of Medicine|September 8, 2006
Clinical practice. Social anxiety disorderFranklin R Schneier
BMJ (Clinical Research Ed.)|September 6, 2003
Social anxiety disorderFranklin R Schneier
Expert Review of Neurotherapeutics|September 10, 2024
When is pharmacological intervention recommended for adults with social anxiety disorder?Franklin R Schneier
Journal of Psychiatric Practice|September 14, 2004
Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatmentKenneth Belzer, Franklin R Schneier
Psychiatry Research|November 4, 2011
Neural response to eye contact and paroxetine treatment in generalized social anxiety disorderFranklin R Schneier, Marc Pomplun, Melissa Sy, et al.
Journal of Anxiety Disorders|June 11, 2022
Development and initial validation of the Visual Social Anxiety Scale (VSAS): Could a picture be worth a thousand words?Raz Massad, Nimrod Hertz-Palmor, Franklin R Schneier, et al.
Psychiatry Research|July 25, 2009
Neural circuitry of submissive behavior in social anxiety disorder: A preliminary study of response to direct eye gazeFranklin R Schneier, Justine M Kent, Ava Star, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2013
Reduced anterior temporal and hippocampal functional connectivity during face processing discriminates individuals with social anxiety disorder from healthy controls and panic disorder, and increases following treatmentSpiro P Pantazatos, Ardesheer Talati, Franklin R Schneier, et al.
The International Journal of Neuropsychopharmacology|November 12, 2003
The evidence-based pharmacological treatment of social anxiety disorderCarlos Blanco, Muhammad S Raza, Franklin R Schneier, et al.
Pageof 7